The elevated expression of apurinic/apyrimidinic endonuclease 1/redox factor 1 (APE1/Ref-1) is associated with poor survival in numerous types of cancer and could be a potential biomarker to predict prognosis in patients with solid tumors [83]. This evidence concerns the gene APEX1 and cancer.